Abstract
A study of 14 personal patients and 16 others in the literature shows that (1) IgD myelomatosis often presents at a significantly younger age than other forms of myelomatosis, and (2) during life extraosseous tumour can be detected in about two-thirds of these patients.
The IgD form represents 1·5% of myelomatosis and shows an increased incidence of osteolytic lesions, hypercalcaemia, and renal failure, together with heavy Bence Jones proteinuria (90% type L).
Like only Bence Jones myelomatosis, the IgD form seems to behave clinically in a more vicious manner.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Axelsson U. The plasma cells of the bone marrow in myelomatosis treated with Alkeran (melphalan). Scand J Haematol. 1966;3(2):123–135. doi: 10.1111/j.1600-0609.1966.tb01433.x. [DOI] [PubMed] [Google Scholar]
- Bachmann R. The diagnostic significance of the serum concentration of pathological proteins (M-components). Acta Med Scand. 1965 Dec;178(6):801–808. doi: 10.1111/j.0954-6820.1965.tb04331.x. [DOI] [PubMed] [Google Scholar]
- Ben-Bassat I., Frand U. I., Isersky C., Ramot B. Plasma cell leukemia with IgD paraprotein. Arch Intern Med. 1968 Apr;121(4):361–364. [PubMed] [Google Scholar]
- Bert G., Fontana F. IgD myeloma. Br Med J. 1968 Apr 13;2(5597):117–117. doi: 10.1136/bmj.2.5597.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dammacco F., Bonomo L. IgD-myelomatosis. Report of a case. Scand J Haematol. 1968;5(3):161–170. doi: 10.1111/j.1600-0609.1968.tb01734.x. [DOI] [PubMed] [Google Scholar]
- Edwards G. A., Zawadzki Z. A. Extraosseous lesions in plasma cell myeloma. A report of six cases. Am J Med. 1967 Aug;43(2):194–205. doi: 10.1016/0002-9343(67)90164-7. [DOI] [PubMed] [Google Scholar]
- Hobbs J. R., Slot G. M., Campbell C. H., Clein G. P., Scott J. T., Crowther D., Swan H. T. Six cases of gamma-D myelomatosis. Lancet. 1966 Sep 17;2(7464):614–618. doi: 10.1016/s0140-6736(66)91927-1. [DOI] [PubMed] [Google Scholar]
- INNES J., NEWALL J. Myelomatosis. Lancet. 1961 Feb 4;1(7171):239–245. doi: 10.1016/s0140-6736(61)91420-9. [DOI] [PubMed] [Google Scholar]
- Klemm D., Schubothe H., Heimpel H., Kasemir H. D. Gamma-D-Paraproteinämie bei Plasmocytom. Klin Wochenschr. 1967 Jun 1;45(11):590–591. doi: 10.1007/BF01719820. [DOI] [PubMed] [Google Scholar]
- ROWE D. S., FAHEY J. L. A NEW CLASS OF HUMAN IMMUNOGLOBULINS. I. A UNIQUE MYELOMA PROTEIN. J Exp Med. 1965 Jan 1;121:171–184. doi: 10.1084/jem.121.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rogentine G. N., Jr, Rowe D. S., Bradley J., Waldmann T. A., Fahey J. L. Metabolism of human immunoglobulin D (IgD). J Clin Invest. 1966 Sep;45(9):1467–1478. doi: 10.1172/JCI105454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spengler G. A., Bütler R., Pflugshaupt R., Lopez V., Barandun S. Gamma-D-Paraproteinämie. Kasuistischer Beitrag an Hand von zwei Beobachtungen. Schweiz Med Wochenschr. 1967 Feb 11;97(6):170–178. [PubMed] [Google Scholar]
- Ventruto V., Quattrin N. Studio di un caso di mielomo IgD. (Prima osservazione italiana) Haematologica. 1966;51(7):545–552. [PubMed] [Google Scholar]
- Wiedermann D., Wiedermann B., Rádl J., Skvaril F., Vaerman J. P. Uber einen Fall von Immunoglobulin-D-Plasmocytom. Schweiz Med Wochenschr. 1967 Feb 18;97(7):207–210. [PubMed] [Google Scholar]
- Zawadzki Z. A., Edwards G. A. M-components in immunoproliferative disorders. Electrophoretic and immunologic analysis of 200 cases. Am J Clin Pathol. 1967 Oct;48(4):418–430. doi: 10.1093/ajcp/48.4.418. [DOI] [PubMed] [Google Scholar]
- Zawadzki Z. A., Rubini J. R. D-myeloma. Report of two cases. Arch Intern Med. 1967 Apr;119(4):387–393. doi: 10.1001/archinte.119.4.387. [DOI] [PubMed] [Google Scholar]